FDA Approves Mercks RSV Drug for Infants

Compartió un vínculo

2025-06-10 15:00:06

The antibody is the second to receive regulatory clearance.The Food and Drug Administration (FDA) has approved Mercks drug for respiratory syncytial virus (RSV) in infants.Regulators cleared Enflonsia,

0 Commentarios 0 Acciones 60 Views